Correlation Between Veracyte and VistaGen Therapeutics
Can any of the company-specific risk be diversified away by investing in both Veracyte and VistaGen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and VistaGen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and VistaGen Therapeutics, you can compare the effects of market volatilities on Veracyte and VistaGen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of VistaGen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and VistaGen Therapeutics.
Diversification Opportunities for Veracyte and VistaGen Therapeutics
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Veracyte and VistaGen is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and VistaGen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VistaGen Therapeutics and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with VistaGen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VistaGen Therapeutics has no effect on the direction of Veracyte i.e., Veracyte and VistaGen Therapeutics go up and down completely randomly.
Pair Corralation between Veracyte and VistaGen Therapeutics
Given the investment horizon of 90 days Veracyte is expected to generate 1.02 times more return on investment than VistaGen Therapeutics. However, Veracyte is 1.02 times more volatile than VistaGen Therapeutics. It trades about 0.34 of its potential returns per unit of risk. VistaGen Therapeutics is currently generating about -0.19 per unit of risk. If you would invest 3,498 in Veracyte on September 3, 2024 and sell it today you would earn a total of 797.00 from holding Veracyte or generate 22.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Veracyte vs. VistaGen Therapeutics
Performance |
| Timeline |
| Veracyte |
| VistaGen Therapeutics |
Veracyte and VistaGen Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and VistaGen Therapeutics
The main advantage of trading using opposite Veracyte and VistaGen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, VistaGen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VistaGen Therapeutics will offset losses from the drop in VistaGen Therapeutics' long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| VistaGen Therapeutics vs. DiaMedica Therapeutics | VistaGen Therapeutics vs. Lyra Therapeutics | VistaGen Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |